Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Neoplasms
  • Solid Tumor
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04144842
Collaborators
Not Provided
Investigators
Study Director: Christina Reimer, MD Alligator Bioscience AB Principal Investigator: Gustav Ullenhag, Dr Department of Oncology, Uppsala University Hospital